AACR logo

More articles from Poster Presentations - Late-Breaking Abstracts

Abstract CT418: A Phase Ib study of BKM120 combined with abiraterone acetate for castrate-resistant, metastatic prostate cancer
Akash Patnaik, Massimo Loda, Justin Kung, Jim Wu, MaryEllen Taplin, Philip Kantoff, Lewis Cantley, Steven Balk, Glenn Bubley

Cancer Research Oct 2014, 74 (19 Supplement) CT418; DOI: 10.1158/1538-7445.AM2014-CT418
Abstract LB-31: Castration induces upregulation of intratumoral androgen biosynthesis and androgen receptor expression in orthotopic VCaP human prostate cancer xenograft model
Matias Knuuttila, Emrah Yatkin, Jenny Kallio, Saija Savolainen, Teemu Daniel Laajala, Tero Aittokallio, Riikka Oksala, Merja Häkkinen, Pekka Keski-Rahkonen, Seppo Auriola, Matti Poutanen, Sari Mäkelä

Cancer Research Oct 2014, 74 (19 Supplement) LB-31; DOI: 10.1158/1538-7445.AM2014-LB-31
Abstract LB-42: A novel method of expansion for low numbers of human CD8+ T cells in metastatic castration-resistant prostate cancer (mCRPC) patients in clinic
Qiang Zhang, Brian Helfand, Ann LeFever, Chung Lee, Timothy Michael Kuzel

Cancer Research Oct 2014, 74 (19 Supplement) LB-42; DOI: 10.1158/1538-7445.AM2014-LB-42
Abstract LB-39: Human cone precursor-derived retinoblastoma tumors
Xiaoliang L. Xu, Hardeep P. Singh, Lu Wang, Donglai Qi, Bradford K. Poulos, David H. Abramson, Suresh C. Jhanwar, David Cobrinik

Cancer Research Oct 2014, 74 (19 Supplement) LB-39; DOI: 10.1158/1538-7445.AM2014-LB-39
Abstract CT415: A Phase I/IIA multicenter clinical trial of the chimeric monoclonal antibody NEO102 (NPC-1C) in adults with refractory pancreatic and colorectal cancer
Muhammad Shaalan Beg, Michael Morse, Sandip P. Patel, Sharon Mavroukakis, Melony Beatson, Philip M. Arlen, Nilofer S. Azad

Cancer Research Oct 2014, 74 (19 Supplement) CT415; DOI: 10.1158/1538-7445.AM2014-CT415
Abstract LB-33: Establishment and application of patient-derived xenograft models for translational research of personalized cancer therapeutics
Hyeji Park, Eun Jin Ju, Jinhyang Choi, Seok Soon Park, Jaesook Park, Jae Hee Lee, Seol Hwa Shin, Seong-Yun Jeong, Si Yeol Song, Eun Kyung Choi

Cancer Research Oct 2014, 74 (19 Supplement) LB-33; DOI: 10.1158/1538-7445.AM2014-LB-33
Abstract CT414: Efficient induction of cellular and humoral immune responses by heterologous prime-boost therapeutic vaccination, involving plasmid DNA and adenoviral vector, in subjects with HER2-expressing breast cancer: Results from a phase Ib study
SUNGBAE KIM, KyungHae Jung, JinHee Ahn, Jeongeun Kim

Cancer Research Oct 2014, 74 (19 Supplement) CT414; DOI: 10.1158/1538-7445.AM2014-CT414
Abstract LB-14: Polyisoprenylated cysteinyl amides as targeted small molecule anti-Ras therapies
Nazarius S. Lamango, Byron J. Aguilar, Augustine T. Nkembo, Randolph Duverna, Felix Amissah, Rosemary A. Poku, Seth Y. Ablordeppey

Cancer Research Oct 2014, 74 (19 Supplement) LB-14; DOI: 10.1158/1538-7445.AM2014-LB-14
Abstract LB-10: Rational design of small molecules targeting the Ras GEF, SOS1
Chris Evelyn, Xin Duan, Jacek Biesiada, William Seibel, Jaroslaw Meller, Yi Zheng

Cancer Research Oct 2014, 74 (19 Supplement) LB-10; DOI: 10.1158/1538-7445.AM2014-LB-10
Abstract LB-43: Unveiling the molecular significance of HO-1 and muskelin interaction: two masterminds behind the morphology and the adhesive behavior of prostate cancer cells
Geraldine Gueron, Jimena Giudice, Alejandra Paez, Pia Valacco, Noelia Carabelos, Federico Schuster, Javier Cotignola, Felipe Jaworski, Daiana Leonardi, Maria Binaghi, Marcelo Marti, Nora Navone, Elba Vazquez

Cancer Research Oct 2014, 74 (19 Supplement) LB-43; DOI: 10.1158/1538-7445.AM2014-LB-43

Main menu

User menu

Search

More articles from Poster Presentations - Late-Breaking Abstracts

Pages

Articles

Info for

About Cancer Research